{"id":"https://openalex.org/W2157445917","doi":"https://doi.org/10.1158/0008-5472.can-05-1056","title":"Benzodithiophenes Potentiate Differentiation of Acute Promyelocytic Leukemia Cells by Lowering the Threshold for Ligand-Mediated Corepressor/Coactivator Exchange with Retinoic Acid Receptor \u03b1 and Enhancing Changes in all-trans-Retinoic Acid\u2013Regulated Gene Expression","display_name":"Benzodithiophenes Potentiate Differentiation of Acute Promyelocytic Leukemia Cells by Lowering the Threshold for Ligand-Mediated Corepressor/Coactivator Exchange with Retinoic Acid Receptor \u03b1 and Enhancing Changes in all-trans-Retinoic Acid\u2013Regulated Gene Expression","publication_year":2005,"publication_date":"2005-09-01","ids":{"openalex":"https://openalex.org/W2157445917","doi":"https://doi.org/10.1158/0008-5472.can-05-1056","mag":"2157445917","pmid":"https://pubmed.ncbi.nlm.nih.gov/16140955"},"language":"en","primary_location":{"id":"doi:10.1158/0008-5472.can-05-1056","doi":"https://doi.org/10.1158/0008-5472.can-05-1056","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.can-05-1056","pdf_url":"https://aacrjournals.org/cancerres/article-pdf/65/17/7856/2537272/7856-7865.pdf","source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://aacrjournals.org/cancerres/article-pdf/65/17/7856/2537272/7856-7865.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5033712077","display_name":"Ke Xu","orcid":"https://orcid.org/0000-0002-2453-4475","observed_orcids":["https://orcid.org/0000-0002-2453-4475","https://orcid.org/0000-0002-3942-2767"]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Ke Xu","raw_affiliation_strings":["1Section of Hemato-Oncology, Institute of Cancer Research, London, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Section of Hemato-Oncology, Institute of Cancer Research, London, United Kingdom;","institution_ids":["https://openalex.org/I142947616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054555531","display_name":"Fabien Guidez","orcid":"https://orcid.org/0000-0003-1380-4473","observed_orcids":["https://orcid.org/0000-0003-1380-4473"]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Fabien Guidez","raw_affiliation_strings":["1Section of Hemato-Oncology, Institute of Cancer Research, London, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Section of Hemato-Oncology, Institute of Cancer Research, London, United Kingdom;","institution_ids":["https://openalex.org/I142947616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061053957","display_name":"Annegret Glasow","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Annegret Glasow","raw_affiliation_strings":["1Section of Hemato-Oncology, Institute of Cancer Research, London, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Section of Hemato-Oncology, Institute of Cancer Research, London, United Kingdom;","institution_ids":["https://openalex.org/I142947616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110363344","display_name":"Danna Chung","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Danna Chung","raw_affiliation_strings":["1Section of Hemato-Oncology, Institute of Cancer Research, London, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Section of Hemato-Oncology, Institute of Cancer Research, London, United Kingdom;","institution_ids":["https://openalex.org/I142947616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028318497","display_name":"Kevin R. Petrie","orcid":"https://orcid.org/0000-0002-9805-9152","observed_orcids":["https://orcid.org/0000-0002-9805-9152"]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Kevin Petrie","raw_affiliation_strings":["1Section of Hemato-Oncology, Institute of Cancer Research, London, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Section of Hemato-Oncology, Institute of Cancer Research, London, United Kingdom;","institution_ids":["https://openalex.org/I142947616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011985711","display_name":"Kimberly Stegmaier","orcid":"https://orcid.org/0000-0003-0218-7895","observed_orcids":["https://orcid.org/0000-0003-0218-7895"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kimberly Stegmaier","raw_affiliation_strings":["2Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts;","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109245721","display_name":"Kan-Kan Wang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801556517","display_name":"Ruijin Hospital","ror":"https://ror.org/01hv94n30","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I2801556517"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Kan-Kan Wang","raw_affiliation_strings":["3State Key Lab for Medical Genomics, Ruijin Hospital, Shanghai Second Medical University, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3State Key Lab for Medical Genomics, Ruijin Hospital, Shanghai Second Medical University, and","institution_ids":["https://openalex.org/I2801556517"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100329272","display_name":"Ji Zhang","orcid":"https://orcid.org/0009-0002-1522-4974","observed_orcids":["https://orcid.org/0009-0002-1522-4974","https://orcid.org/0000-0002-8140-2823"]},"institutions":[{"id":"https://openalex.org/I19820366","display_name":"Chinese Academy of Sciences","ror":"https://ror.org/034t30j35","country_code":"CN","type":"government","lineage":["https://openalex.org/I19820366"]},{"id":"https://openalex.org/I2801556517","display_name":"Ruijin Hospital","ror":"https://ror.org/01hv94n30","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I2801556517"]},{"id":"https://openalex.org/I4210106477","display_name":"Shanghai Institutes for Biological Sciences","ror":"https://ror.org/011rf9d86","country_code":"CN","type":"facility","lineage":["https://openalex.org/I19820366","https://openalex.org/I4210106477"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Ji Zhang","raw_affiliation_strings":["3State Key Lab for Medical Genomics, Ruijin Hospital, Shanghai Second Medical University, and","4Health Science Center, Shanghai Institutes of Biological Science, Chinese Academy of Science and Shanghai Second Medical University, Shanghai, China; and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3State Key Lab for Medical Genomics, Ruijin Hospital, Shanghai Second Medical University, and","institution_ids":["https://openalex.org/I2801556517"]},{"raw_affiliation_string":"4Health Science Center, Shanghai Institutes of Biological Science, Chinese Academy of Science and Shanghai Second Medical University, Shanghai, China; and","institution_ids":["https://openalex.org/I19820366","https://openalex.org/I4210106477"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013338910","display_name":"Yongkui Jing","orcid":"https://orcid.org/0000-0002-7915-8593","observed_orcids":["https://orcid.org/0000-0002-7915-8593"]},"institutions":[{"id":"https://openalex.org/I98704320","display_name":"Icahn School of Medicine at Mount Sinai","ror":"https://ror.org/04a9tmd77","country_code":"US","type":"education","lineage":["https://openalex.org/I1320796813","https://openalex.org/I98704320"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yongkui Jing","raw_affiliation_strings":["5Department of Medicine, Mount Sinai School of Medicine, New York, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Department of Medicine, Mount Sinai School of Medicine, New York, New York","institution_ids":["https://openalex.org/I98704320"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065964317","display_name":"Arthur Zelent","orcid":"https://orcid.org/0000-0002-7968-9888","observed_orcids":["https://orcid.org/0000-0002-7968-9888"]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Arthur Zelent","raw_affiliation_strings":["1Section of Hemato-Oncology, Institute of Cancer Research, London, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Section of Hemato-Oncology, Institute of Cancer Research, London, United Kingdom;","institution_ids":["https://openalex.org/I142947616"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5103695409","display_name":"Samuel Waxman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I98704320","display_name":"Icahn School of Medicine at Mount Sinai","ror":"https://ror.org/04a9tmd77","country_code":"US","type":"education","lineage":["https://openalex.org/I1320796813","https://openalex.org/I98704320"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Samuel Waxman","raw_affiliation_strings":["5Department of Medicine, Mount Sinai School of Medicine, New York, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Department of Medicine, Mount Sinai School of Medicine, New York, New York","institution_ids":["https://openalex.org/I98704320"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":6,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.3097,"has_fulltext":true,"cited_by_count":13,"citation_normalized_percentile":{"value":0.50706171,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"65","issue":"17","first_page":"7856","last_page":"7865"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11072","display_name":"Peroxisome Proliferator-Activated Receptors","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11736","display_name":"Histone Deacetylase Inhibitors Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/benzodithiophene","display_name":"benzodithiophene","score":0.9819999933242798},{"id":"https://openalex.org/keywords/acute-promyelocytic-leukemia","display_name":"acute promyelocytic leukemia","score":0.9909999966621399},{"id":"https://openalex.org/keywords/all-trans-retinoic-acid","display_name":"all-trans retinoic acid","score":0.9259999990463257},{"id":"https://openalex.org/keywords/differentiation-induction","display_name":"differentiation induction","score":0.6480000019073486},{"id":"https://openalex.org/keywords/retinoic-acid-receptor-alpha","display_name":"retinoic acid receptor alpha","score":0.9879999756813049},{"id":"https://openalex.org/keywords/pml-raralpha","display_name":"PML-RAR\u03b1","score":0.8519999980926514},{"id":"https://openalex.org/keywords/histone-acetylation","display_name":"histone acetylation","score":0.7239999771118164},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.7770000100135803}],"concepts":[{"id":"https://openalex.org/C146777309","wikidata":"https://www.wikidata.org/wiki/Q1132599","display_name":"Corepressor","level":5,"score":0.8042526245117188},{"id":"https://openalex.org/C2778001298","wikidata":"https://www.wikidata.org/wiki/Q1036906","display_name":"Histone acetyltransferase","level":4,"score":0.7157584428787231},{"id":"https://openalex.org/C2776601000","wikidata":"https://www.wikidata.org/wiki/Q612108","display_name":"Acute promyelocytic leukemia","level":4,"score":0.6837853789329529},{"id":"https://openalex.org/C2781121885","wikidata":"https://www.wikidata.org/wiki/Q425517","display_name":"Retinoic acid","level":3,"score":0.6501918435096741},{"id":"https://openalex.org/C2778305200","wikidata":"https://www.wikidata.org/wiki/Q174378","display_name":"Histone deacetylase","level":4,"score":0.6008575558662415},{"id":"https://openalex.org/C77445288","wikidata":"https://www.wikidata.org/wiki/Q637488","display_name":"Coactivator","level":4,"score":0.5885813236236572},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5796248912811279},{"id":"https://openalex.org/C120197328","wikidata":"https://www.wikidata.org/wiki/Q2838685","display_name":"Retinoic acid receptor","level":4,"score":0.5230130553245544},{"id":"https://openalex.org/C148738053","wikidata":"https://www.wikidata.org/wiki/Q210861","display_name":"Cellular differentiation","level":3,"score":0.5064069032669067},{"id":"https://openalex.org/C63932345","wikidata":"https://www.wikidata.org/wiki/Q422500","display_name":"Nuclear receptor","level":4,"score":0.48666316270828247},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4705878794193268},{"id":"https://openalex.org/C2779982571","wikidata":"https://www.wikidata.org/wiki/Q25098780","display_name":"Differentiation therapy","level":5,"score":0.46659091114997864},{"id":"https://openalex.org/C119775778","wikidata":"https://www.wikidata.org/wiki/Q18031040","display_name":"Retinoic acid receptor alpha","level":5,"score":0.46091845631599426},{"id":"https://openalex.org/C2779963572","wikidata":"https://www.wikidata.org/wiki/Q29417","display_name":"Tretinoin","level":4,"score":0.445125550031662},{"id":"https://openalex.org/C162253465","wikidata":"https://www.wikidata.org/wiki/Q18031338","display_name":"Retinoid X receptor gamma","level":5,"score":0.41415658593177795},{"id":"https://openalex.org/C119157956","wikidata":"https://www.wikidata.org/wiki/Q796604","display_name":"Acetylation","level":3,"score":0.39416590332984924},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3710845708847046},{"id":"https://openalex.org/C64927066","wikidata":"https://www.wikidata.org/wiki/Q36293","display_name":"Histone","level":3,"score":0.32361239194869995},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.3206212520599365},{"id":"https://openalex.org/C86339819","wikidata":"https://www.wikidata.org/wiki/Q407384","display_name":"Transcription factor","level":3,"score":0.232660710811615},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.07216215133666992}],"mesh":[{"descriptor_ui":"D000072482","descriptor_name":"Retinoic Acid Receptor alpha","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002454","descriptor_name":"Cell Differentiation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012097","descriptor_name":"Repressor Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D013876","descriptor_name":"Thiophenes","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D014162","descriptor_name":"Transfection","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014212","descriptor_name":"Tretinoin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D015473","descriptor_name":"Leukemia, Promyelocytic, Acute","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015473","descriptor_name":"Leukemia, Promyelocytic, Acute","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D015473","descriptor_name":"Leukemia, Promyelocytic, Acute","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015473","descriptor_name":"Leukemia, Promyelocytic, Acute","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D015973","descriptor_name":"Gene Expression Regulation, Leukemic","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D018168","descriptor_name":"Receptors, Retinoic Acid","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D020298","descriptor_name":"U937 Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1158/0008-5472.can-05-1056","doi":"https://doi.org/10.1158/0008-5472.can-05-1056","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.can-05-1056","pdf_url":"https://aacrjournals.org/cancerres/article-pdf/65/17/7856/2537272/7856-7865.pdf","source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},{"id":"pmid:16140955","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16140955","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer research","raw_type":"Journal Article"},{"id":"pmh:oai:sure.sunderland.ac.uk:12424","doi":null,"is_oa":false,"landing_page_url":"http://sure.sunderland.ac.uk/view/creators/Xu=3AKe=3A=3A.html>,","pdf_url":null,"source":{"id":"https://openalex.org/S4306402295","display_name":"Sunderland Repository (University of Sunderland)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I5728261","host_organization_name":"University of Sunderland","host_organization_lineage":["https://openalex.org/I5728261"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"Article"},{"id":"pmh:oai:kclpure.kcl.ac.uk:publications/b13d25bd-bf16-41c0-a0b0-663a44a84c3e","doi":null,"is_oa":false,"landing_page_url":"http://cancerres.aacrjournals.org/reprint/65/17/7856","pdf_url":null,"source":{"id":"https://openalex.org/S4306400216","display_name":"Research Portal (King's College London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I183935753","host_organization_name":"King's College London","host_organization_lineage":["https://openalex.org/I183935753"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Xu, K, Guidez, F, Glasow, A, Chung, D, Petrie, K, Stegmaier, K, Wang, K K, Zhang, J, Jing, Y, Zelent, A & Waxman, S 2005, 'Benzodithiophenes potentiate differentiation of acute promyelocytic leukemia cells by lowering the threshold for ligand-mediated corepressor/coactivator exchange with retinoic acid receptor alpha and enhancing changes in all-trans-retinoic acid-related gene expression.', Cancer Research, vol. 65, no. 17, pp. 7856 - 7865. https://doi.org/10.1158/0008-5472.CAN-05-1056","raw_type":"info:eu-repo/semantics/publishedVersion"}],"best_oa_location":{"id":"doi:10.1158/0008-5472.can-05-1056","doi":"https://doi.org/10.1158/0008-5472.can-05-1056","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.can-05-1056","pdf_url":"https://aacrjournals.org/cancerres/article-pdf/65/17/7856/2537272/7856-7865.pdf","source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9391000270843506,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2157445917.pdf","grobid_xml":"https://content.openalex.org/works/W2157445917.grobid-xml"},"referenced_works_count":47,"referenced_works":["https://openalex.org/W206145882","https://openalex.org/W266859766","https://openalex.org/W1520668250","https://openalex.org/W1550565578","https://openalex.org/W1554600230","https://openalex.org/W1579062391","https://openalex.org/W1598192021","https://openalex.org/W1749479308","https://openalex.org/W1903161793","https://openalex.org/W1964224609","https://openalex.org/W1966322170","https://openalex.org/W1971921506","https://openalex.org/W1981279981","https://openalex.org/W1999440035","https://openalex.org/W2003525122","https://openalex.org/W2004745065","https://openalex.org/W2005496330","https://openalex.org/W2009497362","https://openalex.org/W2012661561","https://openalex.org/W2022177704","https://openalex.org/W2052310806","https://openalex.org/W2054340912","https://openalex.org/W2070392447","https://openalex.org/W2079526924","https://openalex.org/W2085763178","https://openalex.org/W2090573694","https://openalex.org/W2096201820","https://openalex.org/W2096433887","https://openalex.org/W2106734538","https://openalex.org/W2114334107","https://openalex.org/W2117691193","https://openalex.org/W2122449674","https://openalex.org/W2132791225","https://openalex.org/W2137553196","https://openalex.org/W2138492937","https://openalex.org/W2147567567","https://openalex.org/W2156575042","https://openalex.org/W2164954416","https://openalex.org/W2166082601","https://openalex.org/W2235489905","https://openalex.org/W2327237185","https://openalex.org/W2407345634","https://openalex.org/W2412170445","https://openalex.org/W2465676405","https://openalex.org/W2893539009","https://openalex.org/W2951774019","https://openalex.org/W4285719527"],"related_works":["https://openalex.org/W2110777143","https://openalex.org/W2054221105","https://openalex.org/W1932027402","https://openalex.org/W1687574083","https://openalex.org/W2039326434","https://openalex.org/W603214984","https://openalex.org/W7146088551","https://openalex.org/W7099735489","https://openalex.org/W2412170445","https://openalex.org/W7096903647"],"abstract_inverted_index":{"Differentiation":[0],"induction":[1],"is":[2,218],"an":[3,170],"effective":[4],"therapy":[5,202],"for":[6,81,190,199],"acute":[7,208],"promyelocytic":[8],"leukemia":[9,210],"(APL),":[10],"which":[11,213],"dramatically":[12],"responds":[13],"to":[14,169],"all-trans-retinoic":[15],"acid":[16,140],"(ATRA).":[17],"Recent":[18],"studies":[19],"have":[20,121],"indicated":[21],"that":[22,123,148],"combinatorial":[23,200],"use":[24],"of":[25,54,64,98,112,130,154,162,185,203],"retinoid":[26],"and":[27,36,46,93,128,133,178,192,205],"nonretinoid":[28],"compounds,":[29,56,85],"such":[30],"as":[31,61],"histone":[32,78],"deacetylase":[33],"inhibitors,":[34],"arsenics,":[35],"PKA":[37],"agonists,":[38],"has":[39],"higher":[40],"therapeutic":[41],"value":[42],"in":[43,48,76,172,212],"this":[44],"disease":[45],"potentially":[47],"other":[49,207],"malignancies.":[50],"In":[51],"a":[52],"screen":[53],"370":[55],"we":[57,120],"identified":[58],"benzodithiophene":[59,188],"analogues":[60],"potent":[62,84],"enhancers":[63],"ATRA-induced":[65,116],"APL":[66,117,179,204],"cell":[67,118,180],"differentiation.":[68,181],"These":[69,145],"effects":[70,111,174],"were":[71,86,94],"not":[72,101],"associated":[73],"with":[74,138],"changes":[75],"global":[77],"acetylation":[79],"and,":[80],"the":[82,107,110,152,163,183,214],"most":[83],"exerted":[87],"at":[88,151],"very":[89],"low":[90,187],"nanomolar":[91],"concentrations,":[92],"paralleled":[95],"by":[96,158],"enhancement":[97,171],"some,":[99],"but":[100],"all,":[102],"ATRA-modulated":[103],"gene":[104,176],"expressions.":[105],"Investigating":[106],"mechanism":[108],"underlying":[109],"these":[113,186,194],"drugs":[114,195],"on":[115,175],"differentiation,":[119],"shown":[122],"benzodithiophenes":[124,149],"enhance":[125],"ATRA-mediated":[126,173],"dissociation":[127],"association":[129],"corepressor":[131],"N-CoR":[132],"coactivator":[134],"p300":[135],"acetyltransferase,":[136],"respectively,":[137],"retinoic":[139],"receptor":[141,155,164],"(RAR)":[142],"alpha":[143],"proteins.":[144],"data":[146],"suggest":[147],"act":[150],"level":[153],"activation,":[156],"possibly":[157,206],"affecting":[159],"posttranslational":[160],"modification":[161],"(and/or":[165],"coregulators),":[166],"thus":[167],"leading":[168],"expression":[177],"Given":[182],"specificities":[184],"concentrations":[189],"PML-RARalpha":[191],"RARalpha,":[193],"may":[196],"be":[197],"useful":[198],"differentiation":[201],"myelogenous":[209],"subtypes":[211],"overall":[215],"ATRA":[216],"signaling":[217],"suppressed.":[219]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}